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Abstract 
Anaemia is a common pathology associated with many diseases and infections, though its 
physiological effects are poorly understood.  This project aimed to develop a methodology 
for inducing a stable experimental anaemia in Atlantic cod, halibut, and salmon, and thereby 
investigate the physiological impact of anaemia.   
 
Atlantic cod, halibut, and salmon were rendered progressively anaemic by means of 
intraperitoneal injections of 3 µg·g-1 phenylhydrazine in a dimethyl sulfoxide vehicle, 
dissolved in Cortland’s saline.  One injection was sufficient to induce anaemia in Atlantic 
cod, while two injections, one week apart, provided an acceptable reduction in haematocrit 
and haemoglobin for both Atlantic halibut and salmon.   
 
There was a significant reduction in plasma lactate in the phenylhydrazine-injected group of 
Atlantic cod, and plasma glucose was significantly reduced in anaemic and control fish for 
both Atlantic halibut and salmon.  Additionally, there was a significantly lower concentration 
of plasma sodium and chloride in the Cortland’s saline-only control group of Atlantic halibut.  
Peripheral blood smear analysis showed no significant differences in leukocyte proportions in 
any of the species investigated, but there was a marked increase in immature erythrocytes in 
the anaemic groups of all species.   
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1.0 Introduction 
1.1 Anaemia 
Anaemia is a common pathology in aquaculture that can be associated with many different 
causes.  The severity of its presentation can be dictated by the type of anaemia, such as a 
visible skin discoloration associated with haemolytic anaemia (Beutler, 2005).  Also 
determining the extent to which the anaemia becomes a hindrance to the fish are the lifestyle 
and habits of the fish- more active fish would likely have different/more severe effects from 
the same extent of anaemia when compared with their less active, benthic counterparts.   
 
The mode in which anaemia presents clinically can differ between species and the underlying 
cause. However, the general physiological effect of anaemia is likely to be the dysfunction of 
oxygen transport (Prchal, 2005).  The lowered ability of the blood to transport oxygen around 
the body has the result that the supply of oxygen to the tissues will be limited.  This is 
because the partial pressure of the oxygen in the capillaries is insufficient to offload the 
oxygen to the cells.  As a result, there is a decrease in oxygen consumption at the cellular 
level, with the cells depending more heavily on less efficient glycolysis for ATP generation 
(Prchal, 2005).  Another potential effect of anaemia is a decreased oxygen affinity at the 
surface of the erythrocyte.  Small decreases in pH induce the Bohr effect, and cause the 
erythrocytes to release their oxygen (Prchal, 2005).  Under chronic stress, there can be a 
change in the concentration of β-adrenergic receptors on the RBC surface (Perry, Reid, and 
Salama, 1996).  Whether increased or decreased, however, appears to depend on the 
predominant type of circulating “stress” hormone, with high cortisol levels generally 
increasing the receptor concentration, while catecholamines serve to reduce the number of 
receptors (Perry et al., 1996).   
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Hypoxia-inducible transcription factor 1α (HIF-1α) is an important part of the defences 
against hypoxia, as it serves to regulate the transcription of erythropoietin (Prchal, 2005).  
This means that under anaemic conditions there can be an increase in red blood cell 
production.  Also, the animal may compensate for lower oxygen efficiency by increasing 
cardiac output (Prchal, 2005).  This may come in the form of increased stroke volume, 
frequency, or even a remodelling of the heart itself (Simonott and Farrell, 2007).   
 
There are many potential causes of anaemia in the aquatic environment.  Malnutrition and 
disease are two main causes of anaemia in fish.  Malnutrition with respect to specific 
vitamins, for example, thiamine, pyridoxine, folic acid, inositol, biotin, choline, niacin, and 
vitamins E and K, has been documented as having the potential to cause anaemic effects 
(Pillay and Kutty, 2005).  With regard to disease, anaemia is a common pathological sign of 
many different diseases.  Examples include infections with copepods, parasites, lice, or 
cestodes, as well as infectious salmon anaemia (ISA), viral haemorrhagic septicaemia (VHS), 
infectious haematopoietic necrosis (IHN), spring viraemia of carp (SVC), channel catfish 
viral disease (CCVD), coldwater vibriosis, rainbow trout fry anaemia, to name a few (Woo, 
Bruno, and Lim, 2003).   
 
1.2 Anaemia models 
Several models have been developed to investigate experimental anaemia in various species.  
The most common models have generally been induced physically by removing red blood 
cells from circulation (controlled bleeding), or injecting the test animal with a chemical 
compound.  These methods induce different types of anaemia- haemorrhagic anaemia in the 
case of controlled bleeding, and haemolytic anaemia in the case of chemical injection. 
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1.2.1 Haemorrhagic anaemia 
Haemorrhagic anaemia results directly from the loss of blood at a rate greater than the body’s 
ability to produce new cells (Roberts and Rodger, 2001).  Controlled bleeding of a test 
subject can be employed to induce an anaemic state.  This method has been widely used in 
many experiments involving a variety of vertebrates, ranging from rats (Bozzini, Boyer, 
Friedman, Lezón, Norese, and Alippi, 1998) to teleost fishes (Wood, McDonald and 
McMahon, 1982).  Wood, McMahon and McDonald (1979, 1982) employed a method of 
bleeding fish through the caudal vein and centrifuging the blood to separate it into its 
fractions.  Once this was completed, they eventually replaced the plasma and “buffy coat” 
portions, supplemented with a sufficient amount of saline solution to match the initial; blood 
volume. They repeated this process several times, with small amounts of blood so as to 
gradually induce the anaemic state (Wood et al., 1979).  Replacing the volume of blood 
removed with an equivalent volume of saline is necessary to avoid a decrease in blood 
pressure.   
 
1.2.2 Haemolytic anaemia 
Haemolytic anaemia is the result of haemolysis, or a shortening of the lifespan of the red 
blood cells.  There are many known chemical causes of haemolytic anaemia, including 
arsenic, lead, copper, and chlorates (Beutler, 2005).  Generally induced experimentally by 
administering a chemical or drug with haemolytic effects, the anaemia should begin to 
diminish once the source compound and its metabolites are removed from the system.  The 
different agents have various modes of affecting the erythrocyte; arsenic interacts with 
sulfhydral groups, lead inhibits erythrocyte enzymes, including those involved in porphyrin 
metabolism, copper can inhibit enzymes and catalyzes the oxidation of intracellular reduced 
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glutathione (GSH).  In some cases, such as with chlorates, the affected erythrocytes can 
produce Heinz bodies within the cell (Beutler, 2005).   
 
1.3 Phenylhydrazine-induced anaemia 
Phenylhydrazine has been frequently used for its haemolytic properties since its discovery by 
Fischer in 1875 (Berger, 2007).  It has been noted to induce an anaemic condition in various 
species including human, dog, frog, rabbit (Cary, Dobson, and Brooke, 2000), rat (Dornfest, 
Bush, Lapin, Adu, Fulop, and Naughton, 1990), and various species of fish including pinfish, 
Lagodon rhomboids (Cameron and Wohlschlag, 1969), chinook salmon, Oncorhynchus 
tshawytscha (Smith, McLain, and Zaugg, 1971), and rainbow trout, Oncorhynchus mykiss 
Walbaum (Simonott and Farrell, 2007, Jones, 1971).  
 
Phenylhydrazine (PHZ) works as a redox reactive drug, reacting with the haemoglobin of 
erythrocytes, and creating destructive by-products such as benzene, hydrogen peroxide, 
superoxide anion, and the phenyl radical (Shetlar and Hill, 1985).  The speed at which the 
reaction occurs is critically dependent upon the amount of oxygen available, as one molecule 
of unbound O2 is consumed per PHZ reaction (Shetlar and Hill, 1985).  Contrary to other 
cases of haemolytic anaemia in which there is a change in the cell membrane structure (an 
externalization of phosphatidylserine, a signal for phagocytosis), haemolysis by PHZ is the 
result of increased activity of reactive oxygen species (Berger, 2007).  Overall, the 
administration of phenylhydrazine results in a decrease in total haemoglobin and a reduction 
of both red blood cell quantity and packed cell volume.  An increase in the amount of 
haemoglobin per erythrocyte has been seen experimentally, as well as an elevated number of 
reticulocytes (Berger, 2007).  A study in rats indicated that phenylhydrazine can also act to 
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promote a proliferation of lymphoid cells, effectively stimulating the immune system 
(Dornfest et al. 1990).   
 
1.4 Aims 
This thesis aimed to develop a method for inducing a stable and reproducible anaemic state 
that is applicable for multiple species.  Further, it investigated the changes in basic blood 
chemistry parameters that occur in anaemic fish.  The progressive changes in haematocrit and 
haemoglobin concentrations, plasma lactate and glucose content, electrolyte content, and 
white blood cell profiles were tracked in groups of anaemic and control fish, and inter- as 
well as intra-treatment differences were investigated.  It was expected that there would be a 
marked decrease in haematocrit and haemoglobin contents in phenylhydrazine-injected fish, 
as well as an increase in plasma lactate, as has been seen in many anaemia studies (Cameron 
and Wohlschlag, 1969; Olsen, Falk and Reite, 1992; Wood, McDonald, and McMahon, 
1982).  Plasma glucose was expected to increase, as a result of the secondary stress response 
(Iwama, Afonso, and Vijayan, 2006).  A disruption in electrolytes would likely be apparent 
due to the stress of acid imbalance (Lee, Gerking, and Jezierska, 1983).  Changes in the 
proportions of white blood cells were also expected to be seen in the phenylhydrazine-
injected anaemic fish, as other researchers have noted incidences of leukocytosis (in rat: 
Dornfest, Lapin, Naughton, Adu, Korn, and Gordon, 1986).   
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2.0 Materials and Methods 
2.1 Fish Treatment 
All fish used in the experiments were acclimated in 2 x 2 x 0.4 m tanks for a minimum of two 
weeks prior to the start of experimentation.  The tanks were supplied with degassed seawater 
from 250 m depth at a temperature of 7- 9 ºC and oxygen saturation > 90%, under a  
12L: 12D photoperiod.  The Atlantic cod (Gadus morhua) used were obtained from 
Codfarmers AS, Gildeskål, Norway.  The Atlantic halibut (Hippoglossus hippiglossus) were 
two-year old fish obtained from Mørkved Bukta Research Station, reared on-site. The 
Atlantic salmon (Salmo salar) were originally obtained from the Mainstream AS facility at 
Hopen, Norway, and were provided by the Mørkved Bukta Research Station.   
 
At the start of each experiment, randomly selected fish were individually removed from the 
holding tanks with a dipnet and placed into a bath of light anaesthetic (60 mg·l-1 MS- 222, 
Sigma-Aldrich, Oslo Norway).  For each fish, the wet weight was measured to a specificity of 
0.1 g, the total length was recorded to the nearest 1 mm, and an individually numbered and 
colour-coded t-bar tag (Floy tag company, Seattle WA, USA) was inserted into the dorsal fin 
to allow for identification of individual treatments.  A blood sample (of 250-500 µl volume, 
depending on the experiment) was taken from the caudal vein with a 23- gauge needle, 
treated with 5000U ml-1 ammonium heparin (Sigma-Aldrich, Oslo Norway).  Immediately 
following this, the fish were injected intraperitoneally via 23-gauge needle with a volume of 
phenylhydrazine (PHZ)/ dimethylsulfoxide (DMSO)/ Cortland’s saline solution, DMSO/ 
Cortland’s saline solution, or Cortland’s saline solution, which was determined based on the 
individual mass.  Following injection, the fish were recovered in fresh seawater, until 
7 
 
equilibrium was regained and they exhibited regular opercular movement, before they were 
returned to the holding tank.  All fish in a given experiment were held in a single tank.   
 
From the collected blood samples, smaller volumes of 200 and 20 µl were removed for 
haematocrit and haemoglobin analyses, respectively.  A blood smear was also prepared for 
each fish by spreading a small drop of blood on a microscope slide.  The remainder of the 
blood was centrifuged at 8 000 rpm for approximately two minutes and the plasma was 
aspirated, kept on ice, and frozen at -20ºC for later analysis.  
 
2.1.1 Atlantic cod 
2.1.1.1 Experiment one and two 
The purpose of these first experiments was to determine the dose of phenylhydrazine 
necessary to induce a significant and sustainable anaemic state.  In experiment one, a dose of 
10 µg·g-1 PHZ, which had previously been used in rainbow trout (Simonott and Farrell, 
2007), was injected into ten randomly selected fish (average length 33.1 ± 3.7 cm, weight 
384.3 ± 119.0 g).  A blood sample of 200 µl was taken on day zero (injection day), day two, 
and day six.  The second experiment was designed to determine an optimal dose of 
phenylhydrazine for Atlantic cod.  Six fish (30.7 ± 3.2 cm, 325.7 ± 72.8 g) were injected with 
a saline control, six fish (33.4 ± 3.2 cm, 410 ± 196.1 g) with 2.5 µg·g-1, eight fish (31.6 
 ± 3.1 cm, 309 ± 101.7 g) with 5 µg·g-1, and six fish (32.3 ±3.5 cm, 320.5 ± 126.5 g) with 
 8 µg·g-1.  The fish were sampled at day zero, and again after two, seven, and 14 days.  Blood 
smears were not prepared for these samples. 
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2.1.1.2 Experiments three and four 
From experiments one and two, a dosage of 3 µg·g-1 phenylhydrazine provided an optimal 
stable and reproducible anaemic state.  The next step was to investigate the longer-term 
effects of the drug.  Consequently, in the third experiment, 15 fish (average length 32.0  
± 3.3 cm, weight 311.3 ± 70.9 g) were injected with 3 µg·g-1 PHZ/DMSO/Cortland’s saline, 
15 fish (32.2 ± 2.4 cm, 327.9 ± 71.5 g) with DMSO/Cortland’s saline, and six fish (32.4  
± 2.9 cm, 314.5 ± 110.4 g) with Cortland’s saline.  Blood sampling took place at day zero 
(injection), and subsequently at days three, seven, and 14.  The fourth experiment was 
identical in setup to the third, but blood samples were taken less frequently, at days zero, 14, 
and 21.   
 
2.1.2 Atlantic halibut 
To determine the dose of PHZ necessary for the halibut, blood samples were taken from two 
fish to inspect the normal percentage of haematocrit.  A conservative estimate of 3 µg·g-1 
PHZ/ DMSO/ Cortland’s saline was injected into 12 randomly selected fish (average length 
45.5 ± 2.7 cm, weight 1138.0  ± 267.1 g).  Twelve fish (average length 45.9 ±2.6 cm, weight 
1182.6 ± 190.9 g) were injected with DMSO/Cortland’s saline, five fish (average length 44.3 
± 6.1 cm, weight 1031.8 ± 471.1 g) received an injection of Cortland’s saline only, and an 
initial blood sample of 500 µl was taken.  On day seven post-injection, the haematocrit of 
three PHZ-group fish were tested to gauge the severity of the anaemia.  The average packed 
cell volume was still 15.3%, which was above the desired target value of 10% or less.  The 
fish were subsequently injected with a further 3 µg·g-1 of PHZ/DMSO/Cortland’s saline 
solution.  The fish were blood sampled again on days 14, 21, and 28.   
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2.1.3 Atlantic salmon 
Twenty-five (average length 32.4 ± 2.5 cm, weight 366.9 ± 87.2 g) randomly selected salmon 
were injected intraperitoneally with 3 µg·g-1 PHZ/DMSO/Cortland’s saline, 20 fish (33.5  
± 2.6 cm, 404.4 ± 124.5 g) with DMSO/Cortland’s saline, and seven fish (32.2 ± 1.7 cm, 
356.2 ± 60.6 g) with a Cortland’s saline control.  An initial blood sample of 500 µl was taken.  
Blood samples were taken at day zero (from initial experiment start date), day 8, 15, 22, and 
day 26.  On the 8th day, haematocrit in the PHZ-injected group was not sufficiently low 
(mean 29.57% ± 1.30 SE), so all fish were injected a second time with their respective 
solutions.   
 
2.2 Phenylhydrazine preparation 
To prepare the PHZ/ DMSO/ Cortland’s saline solution, 0.03 g each of both phenylhydrazine 
and dimethyl sulfoxide were weighed in a beaker, and enough Cortland’s saline was added to 
reach a final weight of 5 g.  The DMSO/ Cortland’s saline solution was prepared in a similar 
manner, without the addition of PHZ.  The solutions were kept in 2 ml plastic tubes, and new 
solutions were prepared fresh before each experiment. 
 
2.3 Haematocrit analysis 
Haematocrit was measured using a micro haematocrit centrifuge (Heraeus Pico 17, Thermo 
Scientific, Copenhagen Denmark).  Duplicate 100 µl heparinised micro haematocrit tubes 
(BRAND, Germany) per fish were filled with whole blood and centrifuged for five minutes at 
13,500 rpm.  The packed cell volume was determined visually using a haematocrit reader 
card.  The volume was measured to the nearest half percent, and an average of the two tubes 
was taken.   
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2.4 Haemoglobin analysis 
For haemoglobin analysis, 20 µl of whole blood was fixed in 1 ml of Drabkin’s Solution 
(Sigma-Aldrich, Oslo Norway).  A series of haemoglobin standards was prepared using 
bovine haemoglobin (Sigma-Aldrich, Oslo Norway), and a standard curve constructed.  Fifty 
microlitres of the blood-Drabkin’s mixture was diluted with 200 µl of fresh Drabkin’s 
solution to achieve a final dilution factor of 1:5, as required by the procedure provided.  The 
absorbance of the resulting solutions was measured at 540 nm using a microplate reader 
(Tecan Sunrise, Tecan Nordic, Denmark).  The concentration of haemoglobin in each sample 
was calculated from the standard curve.   
 
2.5 Lactate and Glucose 
Plasma lactate was measured using an AccuTrend hand-held lactate meter with BM-Lactate 
test strips (Roche, Mannheim Germany).  Hand-held meters have been used in a number of 
recent studies (Scott, Wood, Sloman, Iftikar, De Boeck, Almeida-Val, Val, 2008; Brown, 
Watson, Bourhill, and Wall, 2008), with good results compared to other analytical methods.  
When available, measurements were made using whole blood as the sample material.  
However, many of the measurements were performed on plasma samples.  In such cases, a 
standard curve was prepared for each new pack of test strips, to account for inter-pack 
differences.  The high- and low-point measurements of the supplied standards were measured 
with the device on “Plasma Mode”, and standard curves were constructed.  The device had a 
lower detection limit of 0.7 mmol·l-1 and an upper limit of 26 mmol·l-1 in plasma mode.  A 
value of zero was used in calculations for samples that had lactate contents below the 
measurable limit.   
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Glucose was measured using an Ascensia Contour hand-held glucose meter with Ascensia 
Microfill glucose test strips (Bayer, Oslo, Norway).  The device was self-calibrating and able 
to handle both whole blood and plasma as the sample material and had a lower detection limit 
of 0.6 mmol·l-1, and an upper limit of 33.3 mmol·l-1.  Plasma was the main material used, 
except in the final round of salmon blood sampling when whole blood was used as the 
medium.   
 
2.6 Electrolyte analysis 
Plasma sodium, chloride, and potassium were measured using a VetStat Electrolyte and 
Blood Gas Analyzer (IDEXX, Kruuse Norge AS, Drøbak, Norway).  Preliminary tests 
indicated that a dilution was required prior to analysis.  The samples were diluted 2:1 with 
deionized water.  Each sample was individually aspirated into the sample chamber and the 
electrolyte concentration values were recorded.   
 
2.7 Blood smears 
A peripheral blood smear was prepared for the initial (pre-injection) and terminal blood 
samples of the Atlantic cod from experiment four, as well as for the Atlantic halibut and 
salmon.  The slides were allowed to completely air dry before they were fixed in methanol, 
stained with Wright’s stain, and cover slipped.  The slides were inspected visually with the 
aid of a microscope under 40-60X magnification and the number and type of white blood 
cells (WBCs) counted.  A minimum of 100 WBCs per slide was counted from non-
contiguous fields.  Representative samples (Figures 1-3) of the cells counted in each cell 
category were photographed.  The relative proportion of immature red blood cells was also 
noted.   
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Figure 1- Atlantic cod blood cells, 60x magnification.  Representative samples of 
immature erythrocytes (1), lymphocytes (2), monocytes (3), neutrophils (4), and 
thrombocytes (5). 
 
 
Figure 2- Atlantic halibut blood cells, 60x magnification.  Representative samples of immature 
erythrocytes (1), lymphocytes (2), monocytes (3), and thrombocytes (4). No neutrophils were 
counted in this species.   
1 
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Figure 3- Atlantic salmon blood cells, 60x magnification.  Representative samples of immature 
erythrocytes (1), lymphocytes (2), monocytes (3), neutrophils (4), and thrombocytes (5).   
 
2.8 Statistical analysis 
Data analysis was completed using SigmaPlot 10 (Systat Software, Chicago, USA).  All data 
was analyzed using one-way ANOVAs, with a Holm-Sidak method for multiple pairwise 
comparisons.  P-values of less than 0.05 were considered significant.  When data was not 
normally distributed or non-homogenous, a Kruskall-Wallis one-way ANOVA on ranks was 
used, followed by Dunn’s Method for pairwise comparisons.  For two-group comparisons, 
Student’s t-test was used, or a Mann-Whitney U test when the equal variance assumption was 
not met.  Z-tests were used to compare the relative proportions of white blood cells in the 
blood smear section.   
1 
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3.0 Results 
3.1 Haematocrit, haemoglobin, and mortality 
3.1.1 Atlantic cod experiments one and two 
3.1.1.1 Haematocrit 
Initial, pre-treatment haematocrit values ranged from 22.9 to 28.3%. At the end of the 
experiment, the values ranged from 14.9-21.4%.  There was a significant reduction in 
haematocrit (Figure 1) after two days in both the 8 and 10 µg·g-1 PHZ groups (t7= 5.746,  
P= < 0.001; t8= 9.521, P= < 0.001).  There was no significant reduction in the 5 µg·g-1  
(F3,13= 2.045, P= 0.157), 2.5 µg·g-1 (F3,15= 2.819, P= 0.075) or 0 µg·g-1 (F3,18= 1.624,  
P= 0.219) groups during the course of the experiment.  There was a significant (F2,10 6.044 
P= 0.025) difference between the final haematocrit values (after 14 days) between the 
different treatments (Figure 4).  The 8 and 10 µg·g-1 PHZ groups were not included in the 
comparison, as there were no survivors (Figure 5).   
 
3.1.1.2 Mortality 
There were heavy losses during this experiment, particularly at the higher doses (Figure 5).  
There was a 100% mortality rate for the two highest doses, 8 and 10 µg·g-1.  There were 
mortalities in each group, with the 0, 2.5, and 5 µg·g-1 groups sustaining 22, 33, and 75% 
losses, respectively (Figure 5).  The deaths in the 0 µg·g-1 control group occurred 
immediately after injection, and there were no further losses.   
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Figure 4- Haematocrit progression, Atlantic cod (Gadus morhua) experiments 1 and 2.  
The 10 µg·g-1 group is represented by diamonds; 8 µg·g-1 by inverted triangles; 5 µg·g-1 
by squares; 2.5 µg·g-1 by triangles, and 0 µg·g-1 by circles.  Significant deviations from 
the initial haematocrit concentrations are represented by a star.  The only differences 
seen were in the second samples from the 8 and 10 µg·g-1 groups.  (After this point, all 
individuals in these groups were deceased) 
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Figure 5- Cumulative mortality, Atlantic cod (Gadus morhua) experiments 1 and 2.  The   
10 µg·g-1 group is represented by filled hexagons; 8 µg·g-1 by light circles; 5 µg·g-1 by 
filled squares; 2.5 µg·g-1 by triangles, and 0 µg·g-1 by dark circles.   
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3.1.2 Atlantic cod experiment three 
3.1.2.1 Haematocrit 
The mean pre-treatment haematocrit concentrations ranged from 27.1 ± 1.68 - 29.1 ± 0.67% 
(Figure 6).  At the end of the experiment, the values ranged from 8 ± 0.00- 24.4 ± 0.95%.  
The phenylhydrazine-injected group showed variation in haematocrit concentrations 
throughout the experiment, with the samples from days 3, 7, and 14 having significantly 
(F2,29= 60.365, P= < 0.001) lower haematocrit values than the initial sample (Figure 6).  The 
DMSO group also had significant differences (F2,38= 6.478, P= < 0.001) in haematocrit 
concentration in the samples from days 7 and 14, when compared to the initial value.  No 
differences, however, were seen in the saline-only group.  There was also a significant 
difference (F2,19 23.134 P= < 0.001) between terminal haematocrit percentages between the 
three treatments (Figure 6).  There were slight (16 and 11%, respectively) reductions in 
haematocrit in the DMSO/Cortland’s saline and Cortland’s saline groups, while The PHZ 
group had a reduction of 71%, from an initial haematocrit of 27.7 ± 1.04 % to 8 ± 0.00%.   
 
3.1.2.2 Haemoglobin 
Mean pre-injection haemoglobin concentrations ranged from 6.52 ± 0.44 - 8.65 ± 0.55 g·dl-1, 
and the terminal means ranged from 2.51 ± 0.72- 5.90 ± 0.37 g·dl-1 (Figure 7). The 
haemoglobin content followed a similar pattern as the haematocrit concentrations (Figure 7).  
There was a significant difference (H3= 33.094, P= < 0.001) in haemoglobin in the 
phenylhydrazine-injected group, with the samples from days 3, 7, and 14 having a lower 
content of haemoglobin than the initial.  There was also a difference in the DMSO/Cortland’s 
saline group, in that the samples from days 7 and 14 had significantly (F3,53= 6.598,  
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P= < 0.001) lowered haemoglobin (Figure 7).  No differences were seen in the saline-only 
group (F3,18= 1.773, P= 0.131).  When the treatments were compared, the phenylhydrazine-
injected group had significantly lower haemoglobin compared to the other treatments  
(F2,18= 10.955, P= < 0.001).   
 
Mean Corpuscular Haemoglobin Concentration 
The mean corpuscular haemoglobin concentration (MCHC) decreased significantly  
(H3= 8.263, P= 0.041) between the second and third samples in the PHZ-injected group, from 
a mean of 33.22 g·dl-1 ± 2.80 SE to 22.14 ± 5.50 g·dl-1 (Figure 8).  It then showed a small, but 
non-significant increase at the final sampling point, to a mean of 22.86 g·dl-1 ± 5.09.  In the 
DMSO group, the final MCHC was substantially lower than those of the first and second 
samples (H3= 12.220, P= 0.007).  This treatment group started with an MCHC of 29.68 g·dl-1 
± 1.75, increased slightly to 30.83 g·dl-1 ± 1.91 by day 3, then progressed to a low of  
24.01 g·dl-1 ± 0.79 after the 14-day experiment (Figure 8).  The saline-only group started with 
an MCHC of 24.68 g·dl-1 ± 2.67, increased to 28.48 g·dl-1 ± 2.12 by day 3, decreased to a low 
of 21.68 g·dl-1 ± 2.57 at day 7, and finished with an MCHC of 22.26 g·dl-1 ± 0.78.  These 
changes, however, were non-significant (H3= 7.091, P= 0.069).   
 
3.1.2.3 Mortality 
There was one mortality in the DMSO/ Cortland’s saline group immediately following 
injection, and no further mortalities (Figure 9).  No fish were lost in the saline control group, 
while there was a cumulative loss of 80% in the PHZ treatment group.   
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Figure 6- Haematocrit progression, Atlantic cod (Gadus morhua) experiment 3.  The 
phenylhydrazine group is represented by circles, the dimethyl sulfoxide group by 
inverted triangles, and the Cortland’s saline-only group by squares.  Arrows indicate 
injection dates, and stars represent haematocrit concentrations that are significantly 
different from the initial.  In the phenylhydrazine group, all haematocrit concentrations 
were significantly different from the initial, and in the dimethyl sulfoxide group, the 
samples from days 7 and 14 were significantly different from the initial.  There were no 
significant differences seen in the Cortland’s saline-only group. 
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Figure 7- Haemoglobin progression, Atlantic cod (Gadus morhua) experiment 3.  The 
phenylhydrazine group is represented by circles, the dimethyl sulfoxide group by 
inverted triangles, and the Cortland’s saline-only group by squares.  Arrows indicate 
injection dates and stars indicate values that are significantly different from initial 
values.  All subsequent samples in the phenylhydrazine group were different than the 
initial, and the samples from days 7 and 14 were significantly different in the dimethyl 
sulfoxide group.  There were no differences seen in the Cortland’s saline-only group. 
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Figure 8- Mean corpuscular haemoglobin concentration changes throughout Atlantic 
cod (Gadus morhua) experiment 3.  The phenylhydrazine group is represented by 
circles, the dimethyl sulfoxide group by inverted triangles, and the Cortland’s saline-
only group by squares.  The arrow indicates the date of injection, and stars indicate 
values that are significantly different.  There was a significant decrease in the 
phenylhydrazine-injected group between days 3 and 7.  In the dimethyl sulfoxide group, 
the sample from day 14 is significantly different than the samples from days zero and 3.  
No changes were seen in the Cortland’s saline-only group. 
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Figure 9- Cumulative mortality, Atlantic cod (Gadus morhua) experiment 3.  The 
phenylhydrazine group is represented by circles, the dimethyl sulfoxide group by 
inverted triangles, and the Cortland's saline-only group by squares. 
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3.1.3 Atlantic cod experiment four 
3.1.3.1 Haematocrit 
Initial mean haematocrit values ranged from 28.1 ± 3.68 SE - 29.2 ± 2.62% (Figure 10).  The 
final values ranged from 17.9 ± 4.01- 25.0 ± 4.14%.  The phenylhydrazine-injected group had 
significant variations in haematocrit (F2,29= 63.805, P= < 0.001), with the samples from days 
14 and 21 having lower concentrations than the initial (Figure 10).  In the DMSO group, the 
sample from day 21 had a lower haematocrit concentration than the initial (F2,38= 5.345,  
P= 0.009).  No differences (F2,12= 2.242, P= 0.149) were seen in the saline-only group, 
though.  There was a significant difference (F2,22= 7.611 P= 0.003) between terminal 
haematocrit values for the different treatments (Figure 10).   
 
3.1.3.2 Haemoglobin 
Before treatments, the mean haemoglobin was between 6.31 ± 0.36 SE - 7.06 ± 0.37 g·dl-1, 
which reduced to between 3.10 ± 0.45 - 6.21 g·dl-1 ± 0.68 by the end of the experiment  
(Figure 11).  There were significant differences (F2,27= 29.798, P= < 0.001) in haemoglobin 
values for the PHZ group throughout the experiment (Figure 11).  However, there were no 
differences in the DMSO (P= 0.323) or saline-only (P= 0.116) groups.  When compared to 
each other, the effect of treatment was apparent, as the phenylhydrazine-injected group had a 
significantly (F2,22= 5.457, P= 0.012) lower final haemoglobin content- 3.10 g·dl-1, when 
compared to the DMSO group (5.30 g·dl-1) and the Cortland’s saline-only group (4.49 g·dl-1).   
 
Mean Corpuscular Haemoglobin Content 
There were no significant changes in MCHC in any of the treatment groups throughout the 
duration of this experiment (Figure 12).  The PHZ group started with an MCHC of  
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20.79 g·dl-1 ± 1.65 SE, which progressed to a low of 17.97 ± 1.45 after 14 days, and increased 
to 18.28 ± 5.54 at day 21 (H2= 5.351, P= 0.069).  The DMSO group showed less variation 
throughout the sampling dates, from the initial 23.22 g·dl-1 ± 0.63, increasing to 24.95 ± 0.53, 
then down to 24.85 ± 2.59 after 21 days (H2= 3.117, P= 0.210).  There was no significant 
difference in MCHC in the Cortland’s saline-only group (F2,12= 0.511, P= 0.613), with an 
initial concentration of 24.38 ± 1.85, and a concentration of 19.06 g·dl-1 ± 5.06 at day 21 
(Figure 12).   
 
3.1.3.3 Mortality 
There was an initial, post-injection mortality of 20% in the PHZ treatment group, 6.7% in the 
DMSO group, and 16.7% in the saline group (Figure 13).  After 21 days, there was 53% 
mortality in the PHZ treatment group, 20% in the DMSO group, and 33% in the Cortland’s 
saline control group.   
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Figure 10- Haematocrit progression, Atlantic cod (Gadus morhua) experiment 4.  The 
phenylhydrazine group is represented by circles, the dimethyl sulfoxide group by 
inverted triangles, and the Cortland's saline-only group by squares.  Arrows represent 
injection dates, and stars indicate haematocrit concentrations that are significantly 
different from the initial.  For the phenylhydrazine group, the samples from days 14 
and 21 were significantly different from day zero, and the haematocrit concentration on 
day 21 in the dimethyl sulfoxide group was significantly lower than the initial.  There 
were no differences seen in the Cortland’s saline-only group. 
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Figure 11- Haemoglobin progression, Atlantic cod (Gadus morhua) experiment 4.  The 
phenylhydrazine group is represented by circles, the dimethyl sulfoxide group by 
inverted triangles, and the Cortland's saline-only group by squares.  Arrows represent 
injection dates and stars represent values that are significantly different from initial 
values.  The samples from days 14 and 21 from the phenylhydrazine group had lower 
haemoglobin content than the initial.   
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Figure 12- Mean corpuscular haemoglobin concentration changes throughout Atlantic 
cod (Gadus morhua) experiment 4.  The phenylhydrazine group is represented by 
circles, the dimethyl sulfoxide group by inverted triangles, and the Cortland’s saline-
only group by squares.  The arrow indicates the injection date.  There were no 
significant differences in MCHC throughout the experiment.   
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Figure 13- Cumulative mortality, Atlantic cod (Gadus morhua) experiment 4.  The 
phenylhydrazine group is represented by circles, the dimethyl sulfoxide group by 
inverted triangles, and the Cortland's saline-only group by squares. 
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3.1.4 Atlantic halibut 
3.1.4.1 Haematocrit 
There was significant variation between haematocrit concentrations in all of the treatment 
groups throughout the experiment (Figure 14).  The mean pre-injection haematocrit ranged 
from 30.50 ± 1.77 SE- 31.88 ± 0.85%.  The end-of-experiment mean haematocrit percentages 
ranged from 7.56 ± 0.60- 25.5 ± 0.74%.  In the PHZ group, the samples from days 14, 21, 
and 28 had significantly lower haematocrit values than the initial (H4= 39.520, P= < 0.001).  
There were significant differences (F4,55= 6.117, P= < 0.001) in all sampling instances for the 
DMSO group, when compared to the initial concentration.  There was a difference between 
the initial and final (day 28) haematocrit values only for the Cortland’s saline-only group 
(F4,20= 4.495, P= 0.009).  In addition, there was a significant difference (F2,25= 138.077  
P= < 0.001) between the final haematocrit values for the three treatments (Figure 14).   
 
3.1.4.2 Haemoglobin  
The haemoglobin content shows a similar progression as was seen for haematocrit (Figure 
15), with initial mean values of 12.16 ± 0.36 SE- 12.48 ± 0.44 g·dl-1, and final contents of 
2.55 ± 0.28- 10.4 ± 0.35 g·dl-1.  All post-injection sampling instances show significantly 
lower haemoglobin content in the phenylhydrazine group (F4,46= 71.429, P= < 0.001).  The 
samples from days 21 and 28 in the DMSO group had lower haemoglobin concentrations 
compared to the initial (F4,53= 4.346, P= 0.004), and the final samples from the saline-only 
group also had lower amounts of haemoglobin (F4,20= 3.553, P= 0.024).  When the different 
treatments were compared, the phenylhydrazine-injected group had a significantly lower 
(F2,21= 151.944, P= < 0.001) haemoglobin content than either the DMSO or saline-only 
groups (Figure 15).   
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Mean Corpuscular Haemoglobin Concentration 
There was a considerate difference (H4= 22.309, P= < 0.001) in MCHC values in the 
phenylhydrazine-injected group throughout the course of the 28-day experiment (Figure 16).  
The group started with an MCHC of 39.39 g·dl-1 ± 0.59 SE, which increased greatly to 45.05 
±1.28 by day 7.  The MCHC remained elevated at the next two sample instances, and starkly 
decreased to 33.82 g·dl-1 ± 2.55 by day 28 (Figure 16).  In the DMSO treatment group, there 
was a substantial (H4= 12.742, P= 0.013) increase in MCHC between the first and second 
samples, from 39.12 ± 0.71 to 44.21 g·dl-1 ± 1.68.  This was the only significant change, and 
the final concentration was 41.63 g·dl-1 ± 1.41.  There were no significant changes  
(H4= 2.496, P= 0.645) in the MCHC of the saline-only group, which had a start concentration 
of 40.47 ± 0.65 and ended at 42.40 g·dl-1 ± 4.18 at day 28 (Figure 16).   
 
3.1.4.3 Mortality 
There were no mortalities in either the DMSO or the Cortland’s saline-only groups  
(Figure 17).  Three mortalities occurred on day 13 in the phenylhydrazine group, for a total 
loss of 25%.  There were no further mortalities in the experiment.   
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Figure 14- Haematocrit progression, Atlantic halibut (Hippoglossus hippoglossus) 
experiment.  The phenylhydrazine group is represented by circles, the dimethyl 
sulfoxide group by inverted triangles, and the Cortland's saline-only group by squares.  
Arrows indicate injection dates.  Stars indicate values that are significantly different 
from initial concentrations.  The phenylhydrazine group had significant differences 
after 14, 21, and 28 days; all samples were significantly different from the initial in the 
dimethyl sulfoxide group, while only the final sample in the Cortland’s saline-only 
group had a significantly different haematocrit percentage.   
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Figure 15- Haemoglobin progression, Atlantic halibut (Hippoglossus hippoglossus) 
experiment.  The phenylhydrazine group is represented by circles, the dimethyl 
sulfoxide group by inverted triangles, and the Cortland's saline-only group by squares.  
Arrows indicate injection dates.  Stars indicate values that are significantly different 
from initial concentrations.  In the phenylhydrazine group, all samples had significantly 
lower haemoglobin than the initial. In both the dimethyl sulfoxide and Cortland’s 
saline-only groups, only the final two samples (days 21 and 28) had significantly 
different concentrations compared to the initial.   
33 
 
Time (days post-injection)
0 5 10 15 20 25 30
M
C
H
C
 (g
.d
l-1
)
32
34
36
38
40
42
44
46
48
50
 
Figure 16- Mean corpuscular haemoglobin concentration changes, Atlantic halibut 
(Hippoglossus hippoglossus) experiment.  The phenylhydrazine group is represented by 
circles, the dimethyl sulfoxide group by inverted triangles, and the Cortland’s saline-
only group by squares.  Arrows indicate injection dates, and stars represent values that 
are significantly different to the initial.  All values in the phenylhydrazine group are 
different from the initial concentration, and there was a significant increase on day 7 in 
the dimethyl sulfoxide group.  There were no differences in the Cortland’s saline-only 
group.   
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Figure 17- Cumulative mortality, Atlantic halibut (Hippoglossus hippoglossus) 
experiment. The phenylhydrazine group is represented by circles, the dimethyl 
sulfoxide group by inverted triangles, and the Cortland's saline-only group by squares.  
There were no mortalities in the dimethyl sulfoxide or Cortland’s saline-only groups, 
and a total mortality of 25% in the phenylhydrazine-injected group.   
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3.1.5 Atlantic salmon 
3.1.5.1 Haematocrit 
Salmon showed an initial, pre-treatment mean haematocrit packed cell volume of 36.67  
± 1.23- 42.14 ± 1.51%, and final values in the experiment were between 13.10 ± 0.91- 27.67 
± 2.62% (Figure 18).  As with the halibut, significant differences in haematocrit percentages 
only came after the second injection (Figure 18).  The phenylhydrazine group saw significant 
reductions (H4=84.339, P= < 0.001), with the samples from days 14, 21, and 25 having lower 
haematocrit than both the initial and day 7 samples.  The average haematocrit percentages in 
the DMSO group were significantly lower (H4= 43.643, P= < 0.001) than initial values in the 
samples from days 14, 21, and 25.  The same differences were seen in the saline-only group 
(F4,24= 9.571, P= < 0.001).  There was a significant difference (H2 24.935 P= < 0.001) in the 
terminal haematocrit values between the three treatment groups, with the phenylhydrazine-
injected group having a significantly lower haematocrit concentration (Figure 18).   
 
3.1.5.2 Haemoglobin 
The initial mean salmon haemoglobin content was between 13.50 g·dl-1 ± 0.49 SE- 14.59  
± 0.75, and final mean concentrations for the groups ranged from 2.74 g·dl-1 ± 0.16- 8.03  
± 0.90 (Figure 19).  Following the second injection, there was a significant (H4= 77.882,  
P= < 0.001) reduction in haemoglobin content in the PHZ group (Figure 19).  For both the 
DMSO and saline-only groups, there were significant reductions in haemoglobin in only the 
fourth and fifth samples (days 21 and 25), when compared to the initial content (DMSO:  
H4= 44.318, P= < 0.001; Saline-only: F4,26= 11.207, P= < 0.001).  Between treatments, the 
phenylhydrazine-injected group had significantly lower haemoglobin content (H2= 24.935, 
P= < 0.001) than both the DMSO and saline-only groups (Figure 19). 
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Mean Corpuscular Haematocrit Concentration 
The MCHC for the phenylhydrazine-injected group varied greatly throughout the experiment 
(Figure 20).  The mean began at a level of 42.17 g·dl-1 ± 1.73 SE, and reduced to 36.67 ±0.76 
at day 7. Following this, there was a significant (H4= 52.308, P= < 0.001) increase to  
45.71 g·dl-1 ± 1.64, a decrease to 30.03 ± 1.45 by day 21, and a further decrease to  
25.27 g·dl-1 ± 3.48 by day 25.  There was less variation in the DMSO group, which started 
with a concentration of 34.77 g·dl-1 ± 0.79, and remained relatively stable until day 21.  By 
day 25, however, there was a significant (H4= 16.132, P= 0.003) decrease in MCHC, to a low 
of 28.54 g·dl-1 ± 2.63 (Figure 20).  There were no apparent significant differences in the 
saline-only treatment group (H4= 9.004, P= 0.061).  There was a high-point of 41.13 g·dl-1  
± 1.09 at day 14, and a low of 32.07 ± 7.29.   
 
3.1.5.3 Mortality 
Following injection, there was an overnight loss of 3 fish from the phenylhydrazine group, 6 
from the DMSO group, and 1 from the saline-only group (Figure 21).  There were no further 
losses during the experiment, giving a cumulative mortality of 12.5% for the PHZ group, 
28.6% for the DMSO group, and 14.3% for the saline-only group.   
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Figure 18- Haematocrit progression- Atlantic salmon (Salmo salar) experiment.  The 
phenylhydrazine group is represented by circles, the dimethyl sulfoxide group by 
inverted triangles, and the Cortland's saline control group by squares.  Arrows indicate 
injection dates.  Stars indicate a significant difference from initial concentration.  The 
values at days 14, 21, and 25 are significantly different from initial values in all groups.   
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Figure 19- Haemoglobin progression, Atlantic salmon (Salmo salar) experiment.  The 
phenylhydrazine group is represented by circles, the dimethyl sulfoxide group by 
inverted triangles, and the Cortland's saline-only group by squares.  Arrows indicate 
injection dates.  Stars indicate a significant difference from initial concentration.  The 
haemoglobin content on days 14, 21, and 25 were significantly lower in the 
phenylhydrazine group.  There was a reduction seen in both the dimethyl sulfoxide and 
Cortland’s saline-only groups on days 21 and 25.   
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Figure 20- Mean corpuscular haemoglobin concentration values, Atlantic salmon 
(Salmo salar) experiment.  The phenylhydrazine group is represented by circles, the 
dimethyl sulfoxide group by inverted triangles, and the Cortland’s saline-only group by 
squares.  Arrows indicate injection dates, and stars indicate values that are significantly 
different.  The samples from days 14, 21, and 25 are significantly different from the 
initial in the phenylhydrazine group. In the dimethyl sulfoxide, there was a reduction at 
day 25, and there were no differences seen in the Cortland’s saline-only group.   
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Figure 21- Cumulative mortality, Atlantic salmon (Salmo salar) experiment.  The 
phenylhydrazine group is represented by circles, the dimethyl sulfoxide group by 
inverted triangles, and the Cortland's saline-only group by squares.  There was a total 
mortality of 12.5% in the phenylhydrazine-injected group, 28.6% in the dimethyl 
sulfoxide group, and 14.3% in the Cortland’s saline-only group. 
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3.2 Lactate and glucose 
3.2.1 Atlantic cod 
Plasma lactate measurements were made on the initial and terminal samples from Atlantic 
cod from experiment four (Table 1).  In the phenylhydrazine group, there was a significant 
difference (U= 83, P= 0.030) between initial and terminal lactate values (3.05 mmol·l-1  
± 0.27 SE vs. 2.49 mmol·l-1 ± 0.27).  There were no differences seen in the DMSO (initial: 
5.43 ± 0.89, final: 3.67 mmol·l-1 ± 5.56; U= 138, P= 0.064) or Cortland’s saline (initial: 3.71 
± 0.49, final: 2.43 mmol·l-1 ± 0.36; t8= 1.902, P= 0.094) groups.  There were also no 
significant concentration differences between the final lactate concentrations for any of the 
treatments (H2= 2.857, P= 0.240).   
 
Plasma glucose measurements were also made on the Atlantic cod from experiment four  
(Table 1).  There were no significant differences in the PHZ (t20= -0.151, P= 0.882), DMSO  
(t26= 0.189, P= 0.852) or Cortland’s saline (t8= 1.180, P= 0.272) groups.  The PHZ group 
started with a concentration of 2.81 ± 0.41 SE and had a final concentration of 2.91 mmol·l-1 
± 0.42.  The DMSO group progressed from 3.33 ± 0.37 to 3.25 mmol·l-1 ± 0.25, while the 
Cortland’s saline group had an initial concentration of 3.45 mmol·l-1 ± 0.65 and ended with a 
final concentration of 2.37 mmol·l-1± 0.51.  Additionally, there were no apparent significant 
differences between treatments, with regard to the final plasma glucose concentrations  
(F2,21= 1.234, P= 0.311).   
 
3.2.2 Atlantic halibut 
All of the halibut plasma samples tested had lactate concentrations below the detection 
threshold of 0.7 mmol·l-1 (Table 1).  There was a significant reduction (U= 81, P= 0.011) in 
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plasma glucose concentration between the initial and final samples in the phenylhydrazine-
injected group (Table 1).  The average glucose content at the beginning of the experiment 
was 1.55 mmol·l-1 ± 0.27 SE, and had reduced to 0.37 mmol·l-1 ± 0.15 by the end.  There 
were also significant reductions in plasma glucose in the DMSO (initial: 1.23 ± 0.14, final: 
0.19 mmol·l-1 ± 0.10; U= 128.5, P= < 0.001) and Cortland’s saline-only groups (initial: 1.62 
± 0.21, final: 0.00 mmol·l-1 ± 0.00; U= 0, P= 0.008).  In the Cortland’s saline only group, all 
final glucose concentrations were below the detection limit.  As there were reductions in each 
group, there were no significant differences seen between terminal concentrations in each of 
the treatments (H2= 3.564, P= 0.168).   
 
3.2.3 Atlantic salmon  
The plasma lactate concentrations showed no significant variation between initial and 
terminal concentrations for neither the phenylhydrazine (initial: 3.82 mmol·l-1 ± 0.17, final: 
3.76 ± 0.20; U=279, P= 0.564), the DMSO (initial: 4.42 mmol·l-1 ± 0.43, final: 3.51 ± 0.27; 
U= 209, P= 0.102), nor the Cortland’s saline only (initial: 5.04 mmol·l-1 ± 0.98, final: 3.51  
± 0.24; U= 28, P= 0.366) groups (Table 1).  There were, similarly, no significant differences 
in final lactate concentrations between the treatment groups (H2= 1.342, P= 0.511).   
 
However, there were significant reductions in plasma glucose in all of the treatment groups.  
The PHZ-injected group saw a reduction (U= 455, P= < 0.001) from 4.92 mmol·l-1 ± 0.17 SE 
to 3.68 mmol·l-1 ± 0.10.  The DMSO group had a significant difference (U= 209, P= < 0.001) 
between the initial concentration of 6.00 mmol·l-1 ± 0.23 and the final, 3.27 mmol·l-1 ± 0.15.  
The Cortland’s saline-only group also saw a significant reduction (t11= 5.016, P= < 0.001) 
between the initial (5.80 mmol·l-1 ± 0.39) and final (3.12 mmol·l-1 ± 0.33) concentrations.  
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There was no variation (H2= 4.202, P= 0.122) in the final glucose concentrations when the 
different treatments were compared to each other.   
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Table 1- Lactate and glucose concentrations. Data are presented as average ± standard 
error. The sample size is written subscript after the mean.  An asterisk represents a 
significant difference between initial and final concentrations.  ND represents ‘no data’.  
There was a significant difference between initial and final mean lactate concentrations 
in the phenylhydrazine-injected group of Atlantic cod.  The mean plasma glucose 
concentrations were significantly different in all treatment groups of Atlantic salmon 
and Atlantic halibut.   
Species Lactate mmol.l-1 (±SE) Glucose mmol.l-1 (±SE) 
Treatment Initial Final Initial Final 
Atlantic  Cod     
PHZ 3.0515
 (±0.27)* 2.497 (±0.27)* 2.8115(±0.41) 2.917 (±0.42) 
DMSO 5.4315 (±0.89) 3.6713 (±0.56) 3.3315 (±0.37) 3.2513 (±0.25) 
Saline 3.716 (±0.49) 2.434 (±0.36) 3.456 (±0.65) 2.374 (±0.51) 
Atlantic Salmon     
PHZ 3.8224 (±0.22) 3.7621 (±0.20) 4.9224
 (±0.17)* 3.6821
 (±0.10)* 
DMSO 4.4221 (±0.43) 3.5115 (±0.27) 6.0021 (±0.23)* 3.2715
 (±0.15)* 
Saline 5.047 (±0.98) 3.516 (±0.24) 5.807
 (±0.39)* 3.126
 (±0.33)* 
Atlantic Halibut     
PHZ nd nd 1.5512
 (±0.27)* 0.378
 (±0.15)* 
DMSO nd nd 1.2312
 (±0.14)* 0.1911
 (±0.10)* 
Saline nd nd 1.625
 (±0.21)* 0.005
 (±0.00)* 
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3.3 Electrolytes 
3.3.1 Atlantic cod 
The terminal plasma samples from Atlantic cod experiment four were used for these analyses.  
There were no significant inter-treatment differences (F2,17= 1.112, P= 0.354) for plasma 
sodium (Table 2).  The PHZ group had an average concentration of: 178.26 mmol·l-1  
± 2.44 SE, DMSO: 174.81 mmol·l-1 ± 2.40, and Cortland’s saline-only: 181.65 mmol·l-1  
± 5.64.  In plasma chloride concentrations, the phenylhydrazine-injected group averaged 
148.44 mmol·l-1 ± 2.60, the dimethyl sulfoxide group 141.81 mmol·l-1± 1.64, and the 
Cortland’s saline-only group 145.91 ± 5.56 mmol·l-1.  There was no significant difference 
between these concentrations (F2,22= 2.012, P= 0.160).  As for plasma potassium 
concentrations, there were also no differences apparent between treatments (F2,22= 1.669,  
P= 0.214), with the phenylhydrazine group averaging 6.64 mmol·l-1 ± 0.21, the DMSO group 
6.03 mmol·l-1 ± 0.13, and the Cortland’s saline group 6.60 mmol·l-1 ± 0.52.   
 
3.3.2 Atlantic halibut 
There was a significant difference (F2,22= 3.868, P= 0.038) in plasma sodium concentrations 
between treatment groups, with the phenylhydrazine group having a higher concentration 
(199.43 mmol·l-1 ± 3.70 SE) compared to the DMSO (192.24 mmol·l-1 ± 0.88) and Cortland’s 
saline (181.72 mmol·l-1 ± 2.08) groups (Table 2).  A significant difference (F2,22= 14.286,  
P= < 0.001) between the three treatment groups with regard to plasma chloride was observed.  
The phenylhydrazine group had a mean content of 171.19 mmol·l-1 ± 3.92, the mean of the 
dimethyl sulfoxide group was 165.82 mmol·l-1 ± 3.66, and the Cortland’s saline group had a 
mean of 136.2 mmol·l-1 ± 2.98.  The difference in these parameters, however, is between the 
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Cortland’s saline control group and the others.  When this group was omitted, there was no 
significant difference between the PHZ and DMSO treatments with regard to sodium  
(t17= 1.380, P= 0.816) and chloride (t17= 0.985, P= 0.338).  There was no significant 
difference (H2= 5.165, P= 0.076) between groups when plasma potassium was analyzed 
(Table 2).  The PHZ group had a mean of 7.33 mmol·l-1 ± 0.28, the DMSO group contained 
8.21 mmol·l-1 ± 0.37, and the Cortland’s saline group averaged 6.71 mmol·l-1 ± 0.46.   
 
3.3.3 Atlantic salmon 
There was no significant difference (F2,40= 0.630, P= 0.538) in plasma sodium between 
groups (Table 2).  The PHZ group had a concentration of 168.00 mmol·l-1 ± 0.87 SE, the 
DMSO group 167.60 mmol·l-1 ± 0.88, and the Cortland’s saline group a concentration of 
166.00 mmol·l-1 ± 1.61.  There were also no significant differences in plasma chloride  
(F2,40= 1.823, P= 0.175).  In this parameter, the phenylhydrazine group had a mean 
concentration of 136.11 mmol·l-1 ± 0.92, while the DMSO group contained on average 
135.32 mmol·l-1 ± 0.87, and the Cortland’s saline group had 132.75 mmol·l-1 ± 1.44.  
Similarly, no differences were seen in plasma potassium (F2,40= 2.305, P= 0.114) between the 
treatment groups, where the PHZ group contained 6.64 mmol·l-1 ± 0.21, the DMSO group 
had 6.03 mmol·l-1 ± 0.13, and the Cortland’s saline group averaged 6.60 mmol·l-1 ± 0.52 
plasma potassium.   
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Table 2- Terminal plasma electrolyte concentrations. Values are presented as mean ± 
standard error.  Sample size is noted in subscript on the treatment type in column 1.  
An asterisk represents a significant difference.  Mean plasma sodium and chloride levels 
in the Atlantic halibut Cortland’s saline-only group were significantly lower than both 
the phenylhydrazine and dimethyl sulfoxide groups. 
Species Sodium mmol.l-1 (±SE) Chloride mmol.l-1 (±SE) Potassium mmol.l-1 (±SE) 
Atlantic Cod    
PHZ7 178.26 (± 2.44) 148.44 (± 2.60) 4.59 (± 0.16) 
DMSO12 174.81 (± 2.40) 141.81 (± 1.64) 4.07 (± 0.19) 
Saline4 181.65 (± 5.64) 145.91 (± 5.56) 4.32 (± 0.33) 
Atlantic Salmon    
PHZ20 168.00 (± 0.87) 136.11 (± 0.92) 6.64 (± 0.21) 
DMSO15 167.60 (± 0.88) 135.32 (± 0.87) 6.03 (± 0.13) 
Saline6 166.00 (± 1.61) 132.75 (± 1.44) 6.60 (± 0.52) 
Atlantic Halibut    
PHZ8 199.43 (± 3.70) 171.19 (± 3.92) 7.33 (± 0.28) 
DMSO11 192.24 (± 3.52) 165.82 (± 3.66) 8.21 (± 0.37) 
Saline4 181.72 (± 2.08)* 136.20 (± 2.98)* 6.71 (± 0.46) 
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3.4 Differential blood counts 
The relative proportions of lymphocytes, thrombocytes, monocytes, and neutrophils were 
measured for each of the sample groups per species (Tables 3, 4).  The before- and after-
treatment proportions within each treatment group were compared using z-tests, but there 
were no significant differences.  The between-treatment proportions (for end-point samples) 
were also tested, but had similarly non-significant results.  There was, however, a marked 
increase in the proportion of immature erythrocytes in each of the phenylhydrazine-treated 
groups post-injection. 
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Table 3- Differential blood smear data, initial proportions.  Values for white blood cells are presented as percentages of total 
number ± SE.  Immature erythrocyte data is presented as percentage of total erythrocytes present.  Subscripts on the 
treatments in column 1 denote the sample size.  There were no significant changes in white blood cell proportions throughout 
the experiments.  There was an increase in the relative proportion of immature erythrocytes in the phenylhydrazine-treated 
groups of all species. 
 
Species 
Treatment Lymphocytes % Thrombocytes % Monocytes % Neutrophils % 
Immature 
Erythrocytes % 
Atlantic Cod Before (±SE) Before (±SE) Before (±SE) Before (±SE) Before 
PHZ7 58.82 (7.40) 26.11 (5.09) 14.95 (2.76) 0.13 (0.13) < 5 
DMSO9 45.96 (1.64) 28.37 (2.92) 25.47 (2.38) 0.01 (0.01) 0 
Saline2 58.97 (3.53) 20.93 (3.11) 20.10 (6.64) 0.00 (0.00) 0 
Atlantic Salmon           
PHZ9 53.67 (4.09) 29.53 (5.05) 11.12 (2.15) 5.68 (1.92) < 5 
DMSO7 53.11 (4.34) 32.50 (5.03) 9.05 (2.10) 5.33 (1.17) < 5 
Saline6 56.34 (2.71) 29.83 (4.40) 7.10 (2.74) 6.73 (1.83) 0 
Atlantic Halibut           
PHZ7 72.26 (4.31) 22.51 (4.18) 5.08 (1.34) 0.16 (0.16) 0 
DMSO7 72.93 (4.01) 21.63 (3.29) 5.39 (1.34) 0.01 (0.01) 0 
Saline3 62.13 (10.20) 29.20 (4.81) 8.68 (5.47) 0.00 (0.00) 0 
 
50 
 
Table 4- Differential blood smear data, final proportions.  Values for white blood cells are presented as percentages of total 
number ± SE.  Immature erythrocyte data is presented as percentage of total erythrocytes present.  Subscripts on the 
treatments in column 1 denote the sample size.  There were no significant changes in white blood cell proportions throughout 
the experiments.  There was an increase in the relative proportion of immature erythrocytes in the phenylhydrazine-treated 
groups of all species. 
 
Species 
Treatment Lymphocytes % Thrombocytes % Monocytes % Neutrophils % 
Immature 
Erythrocytes % 
Atlantic Cod After (±SE) After (±SE) After (±SE) After (±SE) After 
PHZ7 38.31 (6.95) 21.52 (5.97) 39.92 (4.13) 0.25 (0.16) 95 
DMSO9 53.52 (2.93) 19.86 (1.79) 26.62 (2.85) 0.00 (0.00) 5 
Saline2 53.15 (9.86) 23.16 (6.72) 23.69 (3.14) 0.00 (0.00) < 5 
Atlantic Salmon           
PHZ9 48.28 (4.42) 16.42 (4.46) 22.24 (4.77) 13.06 (3.52) 85 
DMSO7 64.90(5.09) 19.03 (3.39) 9.21 (1.64) 6.86 (1.66) < 5 
Saline6 61.41 (6.44) 24.99 (7.82) 8.17 (2.78) 5.43 (1.84) < 5 
Atlantic Halibut           
PHZ7 83.07 (2.79) 7.11 (0.98) 9.75 (3.24) 0.07 (0.07) 90 
DMSO7 79.51 (8.03) 7.56 (1.81) 12.63 (6.90) 0.30 (0.20) < 5 
Saline3 75.59 (9.44) 7.24 (4.39) 17.17 (10.52) 0.00 (0.00) < 5 
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4.0 Discussion 
4.1 Reduction of haematocrit and haemoglobin, mortality 
4.1.1 Atlantic cod experiments one and two 
The purpose of the first two experiments was to determine an appropriate dose of 
phenylhydrazine to induce a stable anaemia in Atlantic cod, while minimizing the subsequent 
mortality.  In experiment one, one dose of 10 µg·g-1 proved too concentrated, as all of the fish 
in the test group died.  For experiment two, several doses of the drug were used to determine 
a more suitable concentration that induced anaemia more gradually, and reduced the 
cumulative mortality.  The 8 µg·g-1 group also had 100% mortality, so the other options were  
2.5 or 5 µg·g-1.  There was an unacceptably high mortality in the 5 µg·g-1 group, while the 
haematocrit was not sufficiently reduced in the 2.5 µg·g-1 group.  The initial blood samples 
from fish that died throughout the experiment were included in subsequent analyses, as they 
were still representative of baseline values.  These mortalities immediately following 
injection were the reason that there was an initial mortality rate of 22%, 25%, and 28.6% in 
the 0 µg·g-1, 5 µg·g-1, and 10 µg·g-1, respectively, which inflated the mortality figures.   
 
Considering the degree of haematocrit reduction as well as mortality numbers, a dose of  
3 µg·g-1 was optimal, and was therefore used for the subsequent experiments, inducing a 
sustained anaemia over the course of two weeks.  This dose is much lower than the 
concentrations used previously for other species, particularly salmonids (rainbow trout:  
10 µg·g-1- Simonott and Farrell, 2007, McClelland, Dalziel, Fragoso, and Moyes, 2005; 
chinook salmon12.5 µg·g-1- Smith et al., 1971). However, Cameron and Wohlschlag (1969) 
used the same concentration for pinfish, with success in reducing both haematocrit and 
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haemoglobin, though the average concentrations for these, 18.8% and 3.70 g·dl-1, 
respectively, were higher than those achieved for Atlantic cod in the present study.   
 
4.1.2 Atlantic cod experiments three and four 
In Atlantic cod experiment 3, there was a decrease in both haemoglobin and haematocrit 
between days zero and 7, but an increase in MCHC.  This suggested that there may have been 
more haemoglobin per erythrocyte, and the fish were essentially making their blood more 
efficient.  This would be beneficial to the fish, as it would lessen the incidence of hypoxia.  
However, in a study on rats, Criswell, Sulkanen, Hochbaum, and Bleavins (2000) found that 
with phenylhydrazine-induced anaemia, there was an increase in free haemoglobin in the 
plasma, which increased the MCHC.  This potentially explained  the increase in this study.  
However, by the next sample instance, the MCHC had significantly reduced.  This can be 
explained by an increase in immature erythrocytes, which have less haemoglobin per cell 
than do mature red blood cells (Valenzuela, Silva, and Klempau, 2006).  The mean 
corpuscular haemoglobin concentration did not appear to follow a discernible pattern in 
relation to the haematocrit and haemoglobin content and is not a reliable gauge for 
interpreting the severity of anaemia.  As with experiments one and two, the mortality data for 
experiments three and four was artificially inflated due to initial, post-injection losses.   
 
In experiment four, the PHZ-group experienced haematocrit reduction by day 14 similar to 
that which was experienced in experiment 3 (11.85% ± 3.21 in experiment 4; 8% ± 0.00 in 
experiment 3), then started to show improvement by day 21, a trend that was mirrored by the 
haemoglobin concentration.  The mean corpuscular haemoglobin concentration showed no 
significant changes in experiment four.  The terminal values for haematocrit and 
haemoglobin in the phenylhydrazine-injected group was still significantly reduced three 
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weeks post-injection.  Smith et al. (1971) undertook a much longer-term investigation of the 
red blood cell counts, haematocrit, and haemoglobin of phenylhydrazine-injected Chinook 
salmon (Onchorynchus tshawytscha).  The fish were intraperitoneally injected with  
12.5 µg·g-1 PHZ and blood samples were taken at 4, 8, 10, 15, 28, 39, and 95 days post-
injection (Smith et al., 1971).  The blood parameters of injected fish only began to near those 
of the controls at 95 days post-injection, although haemoglobin content was still lower  
(5.90 vs. 6.70 g·dl-1 control).   
 
4.1.3 Atlantic halibut 
In the Atlantic halibut experiment, there was a dramatic decrease in both haematocrit and 
haemoglobin in the phenylhydrazine-injected group, with a corresponding significant 
increase in MCHC.  The MCHC increased by day 7, and remained increased through day 21, 
after which it dropped significantly by day 28, which corresponds with the levelling of 
haematocrit and haemoglobin concentrations.  As with the cod experiments, the elevated 
MCHC in this experiment could either indicate an actual increase in the amount of 
haemoglobin per erythrocyte or a false high influenced by free haemoglobin in the plasma (as 
seen in Criswell et al., 2000), although this was not investigated in the present study.  This 
was the only apparent pattern for MCHC in the experiment, as there were no differences in 
the Cortland’s saline-only group, and only a transient post-injection increase in the DMSO 
group.  The low mortality seen in this experiment (3 fish of the PHZ group, for a total of 
25%) indicated that Atlantic halibut are able to deal with an anaemic condition.  Wood et al. 
(1979) demonstrated that the starry flounder (Platichthys stellatus) was tolerant of 
experimental anaemia, surviving with haematocrit levels as low as 1%.   
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4.1.4 Atlantic salmon 
The haematocrit and haemoglobin profiles for the salmon experiment roughly followed that 
of the halibut- for the PHZ group, a slight decrease after the first injection, and further 
decrease after the second dose, followed by a slight increase in haematocrit, while the 
haemoglobin concentration stabilized.  There was no apparent effect of treatment on the 
DMSO or Cortland’s Saline-only groups and the depression of haemoglobin and haematocrit 
levels at the end of the experiment were likely due to repetitive blood sampling.  There was a 
substantial increase in MCHC after the second injection (day 14), which then drastically 
reduced for the samples at days 21 and 25.  The increase in haematocrit with concurrent 
decrease in haemoglobin suggests that the red blood cells were predominately immature, and 
contained less haemoglobin.  Smith et al. (1971) saw a similar lag in haemoglobin recovery 
in phenylhydrazine-injected Chinook salmon for upwards of 95 days, which suggested that 
the haemoglobin content of the blood does not return to control levels until the erythrocytes 
have matured.  Again, as with the Atlantic cod experiments, mortality numbers for this 
experiment were inflated due to the inclusion of baseline data from fish that died on injection 
day.   
 
4.2 Effects on lactate and glucose 
4.2.1 Plasma lactate 
It was expected that there would be an increase in plasma lactate concentration with the 
progression of anaemia.  This phenomenon has been well documented as occurring in many 
experiments involving anaemia (Wood et al., 1982; Mansell, Powell, Ernst, and Nowak, 
2005; Olsen et al., 1992).  In the study by Wood et al. (1982), rainbow trout and starry 
flounder were  made progressively anaemic via blood removal- through either dorsal/ventral 
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aortic cannulae in the case of trout, or caudal vein cannulae in the case of flounder- over a 
period of 4- 6 days in order to study the effects on acid-base regulation.  The experimenters 
noted an overall trend of increased lactate with decreased haematocrit for the rainbow trout, 
although it was quite variable between individual fish (Wood et al., 1982).  However, there 
was no such trend seen in the flounder, which was also the case with the same species and 
similar experimental design investigated by Wood et al. previously (1979).  These data are in 
agreement with the Atlantic halibut data of the current study, where all fish had lactate levels 
that were below detection, and there was no apparent increase.   
 
Increases in lactate concentration with an anaemic state have been documented in studies of 
which the anaemia itself was not the main focus.  Mansell et al. (2005) undertook an 
investigation of the effects on kingfish, Seriola lalandi Valenciennes, of the monogenean 
Zeuxapta seriolae.  This is a gill fluke that feeds directly on the blood of the infected fish.  In 
the experiment, there was a significant decrease in haemoglobin correlated with an increase 
in parasite load.  There was also a marked increase in lactate, which inversely correlated with 
the haemoglobin levels (Mansell et al., 2005).  Olsen et al. (1992) looked into the changes of 
lactate in Atlantic salmon infected with the ISA, infectious salmon anaemia virus.  Much like 
Wood et al. (1982), Olsen et al. (1992) observed a high variance between individual fish with 
regard to blood lactate concentrations in Atlantic salmon, although an overall increase in 
lactate was noted with a decrease in haemoglobin.   
 
In all of the species investigated in the current study, there was a trend toward lower plasma 
lactate concentration at the end of the experiment as compared to initial concentrations.  This 
is despite the significant reductions of haematocrit and haemoglobin in the drug-injected 
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groups.  The only significant lactate reduction, however, was in the phenylhydrazine-injected 
group of Atlantic cod (Table 1).  This group had a mean initial lactate content of  
3.05 mmol·l-1 ± 0.27 SE, and a final content of 2.49 mmol·l-1 ± 0.27.  Although the reduction 
was significant, it was small.  It is worthy of noting, as well, that there were 15 samples in the 
initial group, and only 7 samples in the final group.  It is plausible that the fish that died 
throughout the experiment were those that had elevated plasma lactate levels.  Additionally, 
there was a noticeable lethargy of the phenylhydrazine-injected fish, so there may have been 
some behavioural modifications in order to reduce energy demand.   
 
4.2.2 Plasma glucose 
There were no significant changes in plasma glucose between initial and final samples for 
Atlantic cod in any treatment group, yet there were decreases in all treatment groups in both 
the Atlantic halibut and Atlantic salmon experiments (Table 1).  The fact that there were no 
inter-treatment differences, however, indicates that the reduction of plasma glucose was not a 
result of treatment.  The hypoglycaemia could be a consequence of reduced in food intake 
during the experiment.   
 
4.3 Changes in electrolytes 
There were no significant differences in final (end of experiment) plasma electrolyte 
concentrations for any of the treatment groups for salmon or cod.  This indicated that the 
anaemia did not appear to have a major osmoregulatory effect in these species.  Similar 
results have been reported under hypoxic conditions in other species.  Avilez, Altran, Aguiar, 
and Morales (2004) exposed Brycon cephalus Matrinxa to environmental nitrite (at 
concentrations of 0.2, 0.4, 0.6 mg·l-1), which has been known to have haemolytic effects.  
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Additionally, the nitrite causes the formation of methaemoglobin, which is a non-functioning 
form of haemoglobin for oxygen transport.  There were, however, no major disruptions in ion 
balances in the experiment (Avilez et al., 2004).   
 
In an experiment by Wood and Randall (1971), southern flounder (Paralichthys lethostigma) 
were made anaemic via serial bleeding, and the effects of anaemia on ion exchange were 
studied.  They found that even though the branchial sodium efflux rate was reduced, there 
was no change in plasma sodium levels (Wood and Randall, 1971), suggesting that blood 
electrolyte levels are defended.  In the current Atlantic halibut experiment, there was a 
marked effect of treatment on mean plasma sodium and chloride concentrations.  The 
Cortland’s saline-only group had significantly lower concentrations of these ions when 
compared to the phenylhydrazine and dimethyl sulfoxide groups.  There was, however, no 
difference between the PHZ and DMSO groups.  As the common element between these 
groups was the dimethyl sulfoxide, it can be inferred that it may be this compound that 
caused the difference, and the electrolyte differences were not related to the anaemia.  Indeed, 
while dimethyl sulfoxide is a common biological solvent owing to its amphipathic nature, it 
is not without its side-effects (Santos, Figueira-Coelho, Martins-Silva, and Saldanha, 2003).  
There is a potential osmotic effect of DMSO (Ellison, Velazquez, and Wright, 1984; Santos, 
Figueira-Coelho, Saldanha, and Martins-Silva, 2002), which can lead to an elevation of 
plasma electrolyte concentrations, particularly sodium and potassium (Santos et al., 2002).  
The Atlantic halibut may have been sensitive to the effects of dimethyl sulfoxide.   
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4.4 Differential blood counts 
A differential blood count is a useful tool to investigate the potential immune system effects 
of a treatment.  In the current study, differential blood counts were performed to characterize 
the effects on white blood cell proportions during phenylhydrazine-induced anaemia.  A 
study by Dornfest et al. (1990) investigated the mitogenic effects of phenylhydrazine on rat 
lymphocytes.  The test animals were injected with a single dose of phenylhydrazine, which 
induced haemolytic anaemia.  The anaemia was noted as most severe after 2- 4 days.  
Leukocytosis was apparent, and at its height 4-6 days post-injection, with lymphocytes and 
monocytes accounting for the bulk of the white blood cells.  All of the blood parameters 
investigated returned to baseline levels after 11 days.  They concluded that phenylhydrazine 
caused an increase in lymphoid cells, and was therefore capable of being an immunostimulant 
for the rat (Dornfest et al., 1990).   
 
In the current study, initial (pre-injection) and terminal blood smears were used for 
differential blood count characterization.  The terminal samples were obtained after 21 days 
for Atlantic cod, 28 days for Atlantic halibut, and 25 days for Atlantic salmon.  There was no 
evidence of a significant difference between initial and final white blood cell proportions.  
There are many possible explanations for this observation.  The small sample numbers used 
in this study- between 2 and 9 individuals per group- could surely have an effect on the 
robustness of the data.  Additionally, it is possible that the height of leukocytosis had passed 
by the time the final blood samples had been taken.  Dornfest et al. (1990) reported that blood 
parameters in the rat returned to normal 11 days post-injection.  While the haematocrit and 
haemoglobin values in the current study were still decreased at the end of the experiment, 
they were showing a trend towards increasing.  It is possible that the leukocyte counts were 
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altered earlier in the experiment, but had returned to close to initial levels by the final 
sampling date (14-21 days after final injections).   
 
Furthermore, Dornfest et al. (1986) noted differences in peripheral blood count results when 
an electronic vs. manual method was employed.  In that study, blood samples from 
phenylhydrazine-injected rats was investigated using both electric cell counters, and manual 
means- hemocytometers with light microscopy.  There was an apparent leukocytosis when 
the electric cell counter was used, but it was not detected by manual counting (Dornfest et al., 
1986).  When the cells were investigated under 400X light microscopy, more leukocytes were 
visible in the field.   
 
The haematological effects of anaemia can vary greatly between cases, depending on the 
cause.  Between different pathogens, even, there can be varying pathologies.  While the 
common element is a reduction in haematocrit and packed cell volume, infectious salmon 
anaemia, for example, can also cause a severe leucopenia (Thorud and Djupvik, 1988).  There 
is also evidence that infectious hematopoietic necrosis can also cause leucopenia (Amend and 
Smith, 1975).  This disease presents (in rainbow trout) with a reduction in neutrophils, but an 
increase in lymphocytes, and monocytes are not affected.  There is also evidence of acid-base 
and ion disruptions, with blood chloride and osmolality being reduced.   
 
The effects of a haemorrhagic disease, however, are different.  There are still instances of 
electrolyte imbalances, but the changes are different.  Rehulka (2003) states that viral 
haemorrhagic septicaemia (VHS) can have haematological effects such as decreased total 
protein and creatinine as well as lower levels of blood glucose and sodium.  There can also be 
increases in blood potassium and lactate dehydrogenase levels (Rehulka, 2003).  Generally, 
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infections with parasites and lice, and certain viruses like VHS cause a lower volume of 
blood in circulation, which can have effects on ion, acid-base, and water balance (Roberts 
and Rodger, 2001).  Experimentally-induced anaemia, therefore, is a useful tool for studying 
the physiological effects associated with anaemia-causing diseases, whether they are 
haemolytic or haemorrhagic in nature.   
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5.0 Conclusions 
Phenylhydrazine can be used to induce a stable and reproducible anaemia in each of the 
species studied.  Atlantic cod reach anaemic state after one intraperitoneal injection of  
3 µg·g-1 phenylhydrazine, while two injections, one week apart, work best for Atlantic halibut 
and salmon.  The significant reductions in plasma lactate and glucose seen in the experiments 
were not between-treatment, so phenylhydrazine did not appreciably affect these parameters.  
Future experiments to this extent should include analysis of blood gases to determine if a 
hypoxia is incurred.  Additionally, anaemia does not appear to have a significant effect on 
plasma electrolytes in Atlantic cod or salmon.  There is a potential effect on plasma sodium 
and chloride concentrations in Atlantic halibut.  The potential effects of dimethyl sulfoxide 
on these parameters, however, cannot be discounted.  There was no apparent effect of 
phenylhydrazine-induced experimental anaemia on the relative leukocyte proportions of 
Atlantic cod, Atlantic halibut, or Atlantic salmon.   
62 
 
6.0 References 
Amend, D. F., Smith, L. (1975). Pathophysiology of infectious hematopoietic necrosis virus 
in rainbow trout: haematological and blood chemical changes in moribund fish. 
Infection and Immunity, 11, 171-179.  
Avilez, I. M., Altran, A. E., Aguiar, L. H., Moraes, G. (2004). Hematological responses of the 
Neotropical teleost matrinxa (Brycon cephalus) to environmental nitrite. Comparative 
Biochemistry and Physiology, Part C: Toxicology and Pharmacology, 139, 135-139.  
Berger, J. (2007). Phenylhydrazine haematotoxicity. Journal of Applied Biomedicine, 5, 125-
130.  
Beutler, E. (2005). Hemolytic anemia resulting from chemical and physical agents. In 
Lichtman, M. A., Williams, W. J., Beutler, E., Kaushansky, K., Kipps, T. J., 
Seligsohn, U., and Prchal, J. (Eds.), Williams Hematology (7th edition). Chicago, 
Illinois, USA: McGraw- Hill Professional. pp. 717-721 
Bozzini, C. E., Boyer, P. M., Friedman, S. M., Lezón, Norese, M. F., and Alippi, R. M. 
(1998). Hypophagia-induced hypometabolism during experimental anaemia in rats. 
Comparative Haematology International, 8, 197-201.  
Brown, A. J., Watson, J., Bourhill, A., Wall, T. (2008). Evaluation and use of the lactate pro, 
a portable lactate meter, in monitoring the physiological well-being of farmed Atlantic 
cod (Gadus morhua). Aquaculture, 285, 135-140. 
Cameron, J. N., Wohlschlag, D. E. (1969). Respiratory response to experimentally induced 
anaemia in the pinfish (Lagodon rhomboids). The Journal of Experimental Biology, 
50, 307-317.  
Cary, R., Dobson, S., Brooke, I. (2000). Concise international chemical assessment document 
19: phenylhydrazine. Geneva, Switzerland: Inter-Organization Programme for the 
Sound Management of Chemicals, World Health Organization.   
63 
 
Criswell, K. A., Sulkanen, A. P., Hochbaum, A. F., Bleavins, M. R. (2000). Effects of 
phenylhydrazine or phlebotomy on peripheral blood, bone marrow and erythropoietin 
in wistar rats. Journal of Applied Toxicology, 20, 25-34.  
Dornfest, B. S., Bush, M. E., Lapin, D. M., Adu, S., Fulop, A. and Naughton, B. A. (1990). 
Phenylhydrazine as a mitogen and activator of lymphoid cells. Annals of Clinical and 
Laboratory Science, 20, 353-370. 
Dornfest, B. S., Lapin, D. M., Naughton, B. A., Adu, S., Korn, L., Gordon, A. S. (1986). 
Phenylhydrazine-induced leukocytosis in the rat. Journal of Leukocyte Biology 39, 
37-48. 
Ellison, D. H., Velazquez, H. E., and Wright, F. S. (1984). Osmotic activity of dimethyl 
sulfoxide in the renal distal tubule. Kidney International, 26, 471-475.  
Hirayama, M., Kobiyama, A., Kinoshita, S., Watabe, S. (2004). The occurrence os two types 
of hemopexin-like protein in medaka and differences in their affinity to heme. The 
Journal of Experimental Biology, 207 1382-1398.  
Iwama, G. K., Afonso, L. O. B., Vijayan, M. M. (2006). Stress in fishes. In: Evans, D. H. 
And Claiborne, J. B (eds). The Physiology of Fishes (3rd edition), Boca Raton, 
Florida, USA: CRC Press, pp. 319- 342.  
Jones, D. R. (1971). The effect of hypoxia and anaemia on the swimming performance of 
rainbow trout (Salmo gairdneri). The Journal of Experimental Biology, 55, 541-551.  
Lee, Gerking, and Jezierska. (1983). Electrolyte balance and energy mobilization in acid-
stressed rainbow trout, Salmo gairdneri, and their relation to reproductive success. 
Environmental Biology of Fishes, 8, 115-123.  
McClelland, B., Dalziel, A. C., Fragoso, N. M., Moyes, C. D. (2005). Muscle remodeling in 
relation to blood supply: implications for seasonal changes in mitochondrial enzymes. 
The Journal of Experimental Biology, 208, 515-522.  
64 
 
Olsen, Y. A., Falk, K. Reite, O. B. (1992). Cortisol and lactate levels in Atlantic salmon 
Salmo salar developing infectious anaemia (ISA). Diseases of Aquatic Organisms, 
14, 99-104.  
Perry, S. F., Reid, S. G., Salama, A. (1996). The effects of repeated stress on the β-adrenergic 
response of the rainbow trout red blood cell. The Journal of Experimental Biology, 
199, 549-562.  
Pillay, T. V. R., Kutty, M. N. (2005). Nutrition and feeds. In: Aquaculture: principles and 
practices (2nd Edition). Oxford, United Kingdom: Wiley-Blackwell, pp. 117. 
Prchal, J. (2005). Clinical manifestations and classification of erythrocyte disorders. In 
Lichtman, M. A., Williams, W. J., Beutler, E., Kaushansky, K., Kipps, T. J., 
Seligsohn, U., and Prchal, J. (Eds.), Williams Hematology (7th edition). Chicago, 
Illinois, USA: McGraw- Hill Professional. pp. 411-418 
Rehulka, J. (2003). Haematological analyses of rainbow trout, Oncorhynchus mykiss, affected 
by viral haemorrhagic septicaemia (VHS). Diseases of Aquatic Organisms, 56, 185-
193.  
Roberts, R. J., and Rodger, H. D. (2001). The pathophysiology and systematic pathology of 
teleosts. In: Roberts, R. J. (ed) Fish pathology (3rd edition). Amsterdam, Netherlands: 
Elsevier Health Services. pp. 55-132. 
Santos, N. C., Figueira-Coelho, J., Martins-Silva, and Salldanha, C. (2003). Multidisciplinary 
utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. 
Biochemical Pharmacology, 65, 1035-1041. 
Santos, N. C., Figueira-Coelho, J., Saldanha, C., and Martins-Silva, J. (2002). Biochemical, 
biophysical and haemorheological effects of dimethylsulfoxide on human erythrocyte 
calcium loading. Cell Calcium, 31, 183-188. 
65 
 
Scott, G. R., Wood, C. M., Sloman, K. A., Iftikar, F. I., De Boeck, G., Almeida-Val, V. M. 
F., Val, A. L. (2008). Respiratory responses to progressive hypoxia in the Amazonian 
Oscar, Astronotus ocellatus. Respiratory Physiology and Neurobiology, 162, 109-116. 
Shetlar, M. D., Hill, A. O. (1985). Reactions of haemoglobin with phenylhydrazine: a review 
of selected aspects. Environmental Health Perspectives, 64, 265-281.  
Sidell, B. D., O’Brien, K. M. (2006). When bad things happen to good fish: the loss of 
haemoglobin and myoglobin expression in Antarctis icefishes. The Journal of 
Experimental Biology, 209, 1791-1802. 
Simonott, D.L., Farrell, A.P. (2007). Cardiac remodelling in rainbow trout Oncorhynchus 
mykiss Walbaum in response to phenylhydrazine-induced anaemia. The Journal of 
Experimental Biology. 210, 2574-2584. 
Smith, C. E., McLain, L. R., Zaugg, W. S. (1971). Phenylhydrazine-induced anemia in 
Chinook salmon. Toxicology and Applied Pharmacology, 20, 73-81.  
Thorud, K, Djupvik, H. O. (1988). Infectious anaemia in Atlantic salmon (Salmo salar L.). 
Bulletin of the European Association of Fish Pathologists, 8, 109-111.  
Valenzuela, A. E., Silva, V. M., Klempau, A. E. (2006). Qualitative and quantitative effects 
of constant light photoperiod on rainbow trout (Oncorhynchus mykiss) peripheral 
blood erythrocytes. Aquaculture, 251, 596-602. 
Wicher, K. B., Fries, E. (2006) Haptoglobin, a haemoglobin-binding plasma protein, is 
present in bony fish and mammals but not in frog and chicken. Proceedings of the 
National Academy of Sciences of the United States of America, 103, 4168-4173.  
Woo, P. T. K., Bruno, D. W., Lim, L. H. S. (2003). Diseases and disorders of finfish in cage 
culture. Oxon, United Kingdom: CAB International Publishers. 
Wood, C. M., McDonald, D. G., McMahon, B. R. (1982). The influence of experimental 
anaemia on acid-base regulation in vivo and in vitro in the starry flounder (Platichthys 
66 
 
stellatus) and the rainbow trout (Salmo gairdneri). The Journal of Experimental 
Biology, 96, 221-237.  
Wood, C. M., McMahon, B. R., McDonald, D. G. (1979). Respiratory , ventilatory, and 
cardiovascular responses to experimental anaemia in the starry flounder, Platichthys 
stellatus. The Journal of Experimental Biology, 82, 139-162. 
Wood, C. M. And Randall, D. J. (1971). The effect of anaemia on ion exchange in the 
southern flounder (Paralichthys lethostigma). Comparative Biochemistry and 
Physiology Part A: Physiology, 39, 391-402.  
